2025
SJR Q1
JCR Q2 · 2,3
324 eşleşen makale
SCIE
Dergi ayrıntısı
Pediatric Infectious Disease Journal
- Yayıncı
- Lippincott Williams and Wilkins
- Ülke
- United States · Northern America
- Tür
- journal
- ISSN
-
0891366815320987
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,737
- Quartile Q1
- H-Index 166
- Atıf/yayın 1,7
- Doküman (3y) 1.150
- Atıf (3y) 2.021
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 2,3
- 5Y JIF 2,1
- JCI 0,77
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Infectious Diseases Q2
- Microbiology (medical) Q2
- Pediatrics, Perinatology and Child Health Q1
Alanlar
- Medicine
WoS kategorileri
- Immunology | Infectious Diseases | Pediatrics
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q2 | 0,737 | 2,3 | 2,1 | 0,77 | Q2 | 166 |
| 2024 | Q1 | Q2 | 0,784 | 2,2 | 2,2 | 0,86 | Q2 | 160 |
| 2023 | Q1 | Q1 | 0,888 | 2,9 | 2,4 | 0,92 | Q2 | 160 |
| 2022 | Q1 | Q1 | 1,034 | 3,6 | 2,7 | 0,87 | Q2 | 160 |
| 2021 | Q1 | Q1 | 1,104 | 3,8 | 3 | 0,81 | Q2 | 160 |
| 2020 | Q1 | Q3 | 1,028 | 2,1 | 2,4 | 0,73 | Q2 | 160 |
| 2019 | Q1 | Q2 | 1,139 | 2,1 | 2,3 | 0,79 | Q2 | 160 |
| 2018 | — | Q2 | — | 2,3 | 2,4 | 0,85 | Q2 | — |
| 2017 | Q1 | Q2 | 1,392 | 2,3 | 2,5 | 0,9 | Q2 | 160 |
| 2016 | Q1 | Q1 | 1,557 | 2,5 | 2,7 | — | — | 160 |
| 2015 | Q1 | Q1 | 1,478 | 2,6 | 2,7 | — | — | 160 |
| 2014 | Q1 | Q1 | 1,848 | 2,7 | 2,9 | — | — | 160 |
| 2013 | Q1 | Q1 | 1,654 | 3,1 | 3,2 | — | — | 160 |
| 2012 | Q1 | Q1 | 1,847 | 3,6 | 3,5 | — | — | 160 |
| 2011 | Q1 | Q1 | 1,756 | 3,6 | 3,4 | — | — | 160 |
| 2010 | Q1 | Q1 | 1,728 | 3,1 | 3,3 | — | — | 160 |
| 2009 | — | Q1 | — | 2,9 | 3,3 | — | — | — |
| 2008 | — | Q1 | — | 3,2 | 3,4 | — | — | — |
| 2007 | — | Q1 | — | 3,1 | 3,1 | — | — | — |
| 2006 | — | Q1 | — | 3,2 | — | — | — | — |
| 2005 | — | Q1 | — | 3 | — | — | — | — |
| 2004 | — | Q1 | — | 2,7 | — | — | — | — |
| 2003 | — | Q1 | — | 2,3 | — | — | — | — |
| 2002 | — | Q1 | — | 2,4 | — | — | — | — |
| 2001 | — | Q1 | — | 2,3 | — | — | — | — |
| 2000 | — | Q1 | — | 2,2 | — | — | — | — |
| 1999 | — | Q1 | — | 2 | — | — | — | — |
| 1998 | — | Q1 | — | 2 | — | — | — | — |
| 1997 | — | Q1 | — | 1,9 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | IMMUNOLOGY | SCIE | Q3 | Q2 | 135/183 |
| 2025 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 87/141 |
| 2025 | PEDIATRICS | SCIE | Q2 | Q2 | 55/190 |
| 2024 | IMMUNOLOGY | SCIE | Q3 | Q2 | 135/183 |
| 2024 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 82/137 |
| 2024 | PEDIATRICS | SCIE | Q2 | Q2 | 57/191 |
| 2023 | IMMUNOLOGY | SCIE | Q3 | Q2 | 108/181 |
| 2023 | INFECTIOUS DISEASES | SCIE | Q2 | Q2 | 58/132 |
| 2023 | PEDIATRICS | SCIE | Q1 | Q2 | 29/186 |
| 2022 | IMMUNOLOGY | SCIE | Q3 | Q2 | 99/161 |
| 2022 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 52/96 |
| 2022 | PEDIATRICS | SCIE | Q1 | Q2 | 23/130 |
| 2021 | IMMUNOLOGY | SCIE | Q3 | Q2 | 105/162 |
| 2021 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 56/95 |
| 2021 | PEDIATRICS | SCIE | Q1 | Q2 | 31/130 |
| 2020 | IMMUNOLOGY | SCIE | Q4 | Q2 | 143/162 |
| 2020 | INFECTIOUS DISEASES | SCIE | Q4 | Q2 | 79/93 |
| 2020 | PEDIATRICS | SCIE | Q3 | Q2 | 69/129 |
| 2019 | IMMUNOLOGY | SCIE | Q4 | Q2 | 123/159 |
| 2019 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 69/92 |
| 2019 | PEDIATRICS | SCIE | Q2 | Q2 | 46/128 |
| 2018 | IMMUNOLOGY | SCIE | Q4 | Q2 | 120/158 |
| 2018 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 54/89 |
| 2018 | PEDIATRICS | SCIE | Q2 | Q2 | 39/125 |
| 2017 | IMMUNOLOGY | SCIE | Q3 | Q2 | 113/155 |
| 2017 | INFECTIOUS DISEASES | SCIE | Q3 | Q2 | 54/88 |
| 2017 | PEDIATRICS | SCIE | Q2 | Q2 | 40/124 |
| 2016 | IMMUNOLOGY | SCIE | Q3 | — | 99/151 |
| 2016 | INFECTIOUS DISEASES | SCIE | Q3 | — | 43/84 |
| 2016 | PEDIATRICS | SCIE | Q1 | — | 27/121 |
| 2015 | IMMUNOLOGY | SCIE | Q3 | — | 84/151 |
| 2015 | INFECTIOUS DISEASES | SCIE | Q2 | — | 38/83 |
| 2015 | PEDIATRICS | SCIE | Q1 | — | 22/120 |
| 2014 | IMMUNOLOGY | SCIE | Q3 | — | 75/148 |
| 2014 | INFECTIOUS DISEASES | SCIE | Q2 | — | 34/78 |
| 2014 | PEDIATRICS | SCIE | Q1 | — | 19/120 |
| 2013 | IMMUNOLOGY | SCIE | Q2 | — | 63/144 |
| 2013 | INFECTIOUS DISEASES | SCIE | Q2 | — | 25/72 |
| 2013 | PEDIATRICS | SCIE | Q1 | — | 9/118 |
| 2012 | IMMUNOLOGY | SCIE | Q2 | — | 45/137 |
| 2012 | INFECTIOUS DISEASES | SCIE | Q2 | — | 18/70 |
| 2012 | PEDIATRICS | SCIE | Q1 | — | 6/122 |
| 2011 | IMMUNOLOGY | SCIE | Q2 | — | 46/139 |
| 2011 | INFECTIOUS DISEASES | SCIE | Q2 | — | 19/70 |
| 2011 | PEDIATRICS | SCIE | Q1 | — | 7/115 |
| 2010 | IMMUNOLOGY | SCIE | Q2 | — | 57/134 |
| 2010 | INFECTIOUS DISEASES | SCIE | Q2 | — | 22/58 |
| 2010 | PEDIATRICS | SCIE | Q1 | — | 9/109 |
| 2009 | IMMUNOLOGY | SCIE | Q2 | — | 60/128 |
| 2009 | INFECTIOUS DISEASES | SCIE | Q2 | — | 20/57 |
| 2009 | PEDIATRICS | SCIE | Q1 | — | 8/94 |
| 2008 | IMMUNOLOGY | SCIE | Q2 | — | 47/121 |
| 2008 | INFECTIOUS DISEASES | SCIE | Q2 | — | 14/51 |
| 2008 | PEDIATRICS | SCIE | Q1 | — | 7/86 |
| 2007 | IMMUNOLOGY | SCIE | Q2 | — | 46/119 |
| 2007 | INFECTIOUS DISEASES | SCIE | Q2 | — | 13/50 |
| 2007 | PEDIATRICS | SCIE | Q1 | — | 6/78 |
| 2006 | IMMUNOLOGY | SCIE | Q2 | — | 40/117 |
| 2006 | INFECTIOUS DISEASES | SCIE | Q2 | — | 16/47 |
| 2006 | PEDIATRICS | SCIE | Q1 | — | 5/74 |
| 2005 | IMMUNOLOGY | SCIE | Q2 | — | 41/115 |
| 2005 | INFECTIOUS DISEASES | SCIE | Q2 | — | 11/43 |
| 2005 | PEDIATRICS | SCIE | Q1 | — | 5/73 |
| 2004 | IMMUNOLOGY | SCIE | Q2 | — | 39/111 |
| 2004 | INFECTIOUS DISEASES | SCIE | Q2 | — | 13/41 |
| 2004 | PEDIATRICS | SCIE | Q1 | — | 7/70 |
| 2003 | IMMUNOLOGY | SCIE | Q2 | — | 51/114 |
| 2003 | INFECTIOUS DISEASES | SCIE | Q2 | — | 13/41 |
| 2003 | PEDIATRICS | SCIE | Q1 | — | 7/68 |
| 2002 | IMMUNOLOGY | SCIE | Q2 | — | 48/119 |
| 2002 | INFECTIOUS DISEASES | SCIE | Q2 | — | 12/38 |
| 2002 | PEDIATRICS | SCIE | Q1 | — | 6/68 |
| 2001 | IMMUNOLOGY | SCIE | Q2 | — | 45/114 |
| 2001 | INFECTIOUS DISEASES | SCIE | Q2 | — | 16/37 |
| 2001 | PEDIATRICS | SCIE | Q1 | — | 6/69 |
| 2000 | IMMUNOLOGY | SCIE | Q2 | — | 49/116 |
| 2000 | INFECTIOUS DISEASES | SCIE | Q2 | — | 13/36 |
| 2000 | PEDIATRICS | SCIE | Q1 | — | 5/71 |
| 1999 | IMMUNOLOGY | SCIE | Q2 | — | 49/115 |
| 1999 | INFECTIOUS DISEASES | SCIE | Q2 | — | 16/35 |
| 1999 | PEDIATRICS | SCIE | Q1 | — | 7/72 |
| 1998 | IMMUNOLOGY | SCIE | Q2 | — | 44/120 |
| 1998 | INFECTIOUS DISEASES | SCIE | Q2 | — | 15/36 |
| 1998 | PEDIATRICS | SCIE | Q1 | — | 5/71 |
| 1997 | IMMUNOLOGY | SCIE | Q2 | — | 46/117 |
| 1997 | INFECTIOUS DISEASES | SCIE | Q2 | — | 14/34 |
| 1997 | PEDIATRICS | SCIE | Q1 | — | 7/66 |